Thanks, operator, and welcome, everyone. I'm joined today by Chris Blunt, Chief Executive Officer; and Conor Murphy, President and Chief Financial Officer.

Today's earnings call may include forward-looking statements and projections under the Private Securities Litigation Reform Act, which do not guarantee future events or performance. We do not undertake any duty to revise or update such statements to reflect new information, subsequent events, or changes in strategy.

Please refer to our most recent quarterly and annual reports and other SEC filings for details on important factors that could cause actual results to differ materially from those expressed or implied. This morning's discussion also includes non-GAAP measures, which management believes are relevant in assessing the financial performance of the business.

Non-GAAP measures have been reconciled to GAAP, where required and in accordance with SEC rules, within our earnings materials available on the company's investor website. Please note that today's call is being recorded and will be available for webcast replay.

With that, I'll hand the call over to Chris Blunt.

Good morning, and thanks for joining today's call. We delivered a strong finish to an outstanding year through disciplined growth and the proven ability and flexibility of our business model as we transition to be more fee-based, higher margin, and less capital intensive, and we remain focused on creating long-term shareholder value.

We are executing on our strategy and made further progress toward our 2023 investor day targets as we achieved record AUM before flow reinsurance fueled by one of our best years of sales; excellent performance in our high-quality, diversified investment portfolio; strong performance across our business balanced with diligent expense management; and a healthy financial and capital position. I'd especially like to thank our employees.

Their hard work and dedication are truly the foundation of everything we achieve for our business and for our customers. Now looking at our results more closely, we achieved record AUM before flow reinsurance of $73.1 billion, up 12% over year-end 2024, as well as record retained AUM of $57.6 billion, up 7% over year-end 2024.

This record AUM was driven by $14.6 billion of gross sales, our second-highest year on record. 2025 demonstrated our commitment to manage growth for the long term as we prioritize pricing discipline and capital allocation to the highest-return opportunities.

For the full year, we delivered $9 billion of core sales, including indexed annuities, indexed universal life, and pension risk transfer; and $5.6 billion of opportunistic sales, including MYGA and funding agreements. Conor will provide more details on sales later in the call.

Next, turning to the investment portfolio. Our high-quality, diversified portfolio is performing very well.

The retained portfolio is high quality, with 97% of fixed maturities being investment grade at year-end. Since 2020, we have selectively repositioned over $2 billion of assets to optimize, de-risk, and position the portfolio to perform in varying market conditions, while also improving credit quality.

Credit-related impairments have remained stable at 8 basis points in 2025, well below our pricing assumption. This brings our five-year average since 2021 to 6 basis points, which is exceptionally low.

Our fixed income yield was 4.65% in the fourth quarter, up 6 basis points over the fourth quarter of 2024. As a reminder, our fixed income yield excludes alternative investment income as well as variable investment income, which we define as prepayment fees.

Looking at our alternative investment portfolio, our annualized return was approximately 7% in the fourth quarter as compared to our 10% long-term expected return. At year-end, approximately 40% or $4 billion of our $11 billion alternative investment portfolio was comprised of equity interests, including limited partnerships, with the remaining 60% being investment-grade fixed income debt with more predictable levels of investment income.

Starting in the first quarter of 2026, we are updating our long-term expected return for alternative investments to reflect only the 40% or $4 billion of equity interests. We will reclassify the remaining 60% or nearly $7 billion into our fixed income yield and AUM as shown in the investment income and yield table on page 8 in our financial supplement.

We believe this will more appropriately delineate between the fixed income portfolio and alternative investments while also improving comparability to others in the industry. This disclosure refinement will not have any impact to adjusted net earnings on an as-reported basis.

We're often asked about the effect of short-term interest rates on our business following the recent Fed rate cuts. Given the nature of our spread-based business, longer-term rates and the shape of the yield curve are more significant to us than short-term interest rates.

We do not have significant exposure to changes in short-term interest rates as we have hedged a majority of our floating-rate portfolio to lock in higher rates over the past couple of years. Our floating-rate exposure is now only $2.8 billion or approximately 5% of our total portfolio net of hedging.

Another consideration is variable investment income. We reported $7 million of pre-tax prepayment fees in the fourth quarter.

This brought the full year to $56 million, in line with full year 2024. As a reminder, prepayments fluctuate quarter to quarter and could present a headwind in 2026 if bond prepayments vary from 2025 levels, depending on market conditions.

As far as our asset managers go, we really think we have the best of both worlds in terms of our competitive positioning and flexibility. We are now in the ninth year of our strong and seasoned relationship with a world-class manager in Blackstone, and we have the flexibility to work with other asset managers, whether for flow reinsurance or specialty asset classes that complement Blackstone's capabilities.

Blackstone employs a robust and thorough underwriting approach by developing its own forecasts based on conservative macroeconomic views and historical sector performance. Next, turning to private asset origination, which is a key component of our investment strategy and represents 20% or $11 billion of our retained portfolio.

Here, we utilize Blackstone's best-in-class origination, underwriting, and structuring teams to source high-quality pools of physical and financial assets. These include corporate and commercial lending, consumer loans, real estate, and other real asset exposures.

When it comes to private asset origination, most of these directly originated asset classes have been in existence for decades within the bank channel and have long performance histories over multiple market cycles, providing observable data for thorough underwriting. Private asset originations allow us to mitigate our credit risk in a couple of ways.

They provide diversification to investments that we can access through public markets, and the bilateral nature of these private origination transactions allows us to perform comprehensive analysis on an asset-by-asset basis and incorporate stronger covenant protections relative to the public markets. From a ratings perspective, our private asset origination portfolio has a strong credit profile.

Approximately 92% of the private origination debt portfolio is investment grade and included within the 97% investment grade for our total fixed income portfolio. We primarily use the top five nationally recognized statistical rating organizations.

Approximately 90% of the private origination debt portfolio and 94% of our total fixed income portfolio are rated by a combination of the top five agencies, including Moody's, S&P, Fitch, Kroll, and DBRS. Egan-Jones ratings are de minimis at less than 1% of our total retained portfolio.

Private letter ratings account for approximately 17% of our total retained portfolio and undergo the same analytical rigor as public ratings. The combination of Blackstone's structuring talent, our ability to complement Blackstone's ability with other asset managers, the track record of these assets, and our thorough due diligence has helped generate attractive risk-adjusted returns for F&G that have performed very well to date and through stress environments like the COVID pandemic.

We have refreshed our annual portfolio stress test, which is conservative and assumes no management action. Once again, the stress test has confirmed that our portfolio is well-positioned to withstand a sharp downturn in the economy.

In summary, we feel comfortable and confident in the credit soundness of our investment portfolio. Please see our winter 2025 investor presentation for further details on our stress tests.

Next, I'd like to provide an update on our strong progress toward our 2023 investor day medium-term financial targets, now that we are at the midpoint of our five-year horizon. We have grown AUM before flow reinsurance from the $51 billion baseline to $73 billion at year-end 2025, a 44% increase at the midpoint mark as compared to our target of 50% in five years.

We have expanded ROA, excluding significant items, from the 110 basis point baseline and made significant progress toward the lower end of the 133 to 155 basis point targeted range. We have increased ROE, excluding AOCI and significant items, from the 10% baseline and are closing in on the lower end of the 13% to 14% targeted range.

The preferred stock investment from FNF in 2024, combined with our own internal capital generation, enabled us to grow significantly faster than originally projected when we set our investor day targets. On December 31st, FNF completed the distribution of approximately 12% of the outstanding shares of F&G's common stock to FNF shareholders.

Following the distribution, FNF retains control and a majority ownership with approximately 70% of the outstanding shares in F&G. This has increased F&G's public float from approximately 18% to approximately 30% after the distribution, strengthening F&G's positioning within the equity markets and facilitating greater institutional ownership.

This distribution reflects FNF's confidence in F&G's long-term prospects and is intended to unlock shareholder value by enhancing market liquidity and broadening investor access to F&G shares. On a standalone basis, we reported GAAP common equity excluding AOCI of $6 billion at year-end, and we have grown book value per share excluding AOCI to $44.43, up 62% since the 2020 acquisition.

In summary, F&G finished the year strong. I'm excited about the future and our ability to continue to deliver long-term shareholder value.

Looking ahead, F&G has differentiated capabilities and is uniquely positioned in the industry. We have made significant progress executing on our strategy, leveraging the strength of our distribution partners to continue to grow our spread-based business alongside our growing sources of fee-based, higher margin, and less capital intensive earnings through our flow reinsurance, middle-market life insurance, and owned distribution strategies, all of which is showing up in our results as expected.

Let me now turn the call over to Conor to provide further details on F&G's fourth quarter and full year highlights.

Thank you, Chris. This morning, I will provide some additional details of our sales, fourth quarter and full year earnings and performance drivers, and our strong capital position.

Starting with sales, as Chris mentioned at the beginning of the call, we generated $14.6 billion of gross sales for the full year, including $3.4 billion in the fourth quarter. We had $9 billion of gross sales of our core products, including indexed annuities, indexed universal life, and pension risk transfer.

For the full year, this was our second year of more than $9 billion in core sales. This includes $2.8 billion of core sales in the quarter, in line with the fourth quarter of 2024 and up 27% over the sequential third quarter.

To provide a few highlights of our core sales, indexed annuities were $6.7 billion for the full year, which was in line with full year 2024, and included $1.9 billion of indexed annuities in the quarter, up 12% over the fourth quarter of 2024. This is a strong result in a competitive environment and coming off a record 2024 for fixed indexed annuity sales for both F&G and the industry.

FIA is our largest contributor to indexed annuity sales and progressively increased during 2025, with modest but increasing RILA sales throughout the year. IUL sales were $190 million for the full year, including over $50 million in the quarter, and reflect a 14% increase over full year 2024.

Our life insurance solutions are meeting the needs of the underserved multicultural middle market, which is driving continued steady growth. PRT sales were $2.1 billion for the full year, including over $800 million in the quarter.

This result marks our third consecutive year attaining $2 billion or more in PRT sales and landed squarely in our $1.5 to $2.5 billion targeted annual range. We continue to see a robust PRT pipeline for mid-sized deals up to $500 million, where F&G competes well.

Gross sales of our opportunistic products, including funding agreements and multi-year guaranteed annuities, were $5.6 billion for the full year, including over $600 million in the fourth quarter. Opportunistic sales volumes fluctuate quarter to quarter, depending on economics and market opportunity.

To provide a few highlights, funding agreements were $1.8 billion for the full year, up nearly 80% over the $1 billion in full year 2024. This included nearly $300 million of funding agreements in the quarter, as compared to no funding agreements in the fourth quarter of 2024.

As we entered 2026, we took advantage of an attractive market window and successfully executed a $750 million FABN issuance in early January as we continue to expand our high-quality investor base. MYGA sales were $3.8 billion for the full year, including over $350 million in the quarter, as compared to $5.1 billion in 2024, including nearly $650 million in the fourth quarter of 2024.

We have intentionally moderated MYGA volumes from the prior year level, given market conditions, competitive dynamics, and flow reinsurance optimization, as we continued pricing discipline and allocating capital to the highest-return opportunities throughout the year. F&G's net sales retained were $10 billion for the full year 2025, as compared to $10.6 billion in full year 2024.

This included $2.3 billion of net sales in the quarter, down slightly from the fourth quarter of 2024. Stepping back, 2025 showcased the diversity of our new business engine, allowing us to flex across our products and channels to source the most attractive liabilities in a given environment.

We are also uniquely positioned with our third-party MYGA flow reinsurance partners to dynamically adjust volumes up and down as the market economics change. This is now supplemented via reinsurance sidecar, and we expect our mix of sales to shift more toward FIA over time.

As one of the industry's largest sellers of annuities and life insurance, our model is sustainable and allows us to optimize and position the business for long-term success. This aligns our interests well with the continued strong secular demand by consumers and financial advisors for retirement savings solutions, including our core indexed annuity and indexed life products.

Turning to earnings, on a reported basis, adjusted net earnings were $123 million or $0.91 per share in the fourth quarter. Alternative investment income was $65 million or $0.47 per share below management's long-term expected return for the quarter.

For the full year, on a reported basis, adjusted net earnings were $482 million or $3.64 per share. Alternative investment income was $278 million or $2.03 per share below management's long-term expected return for the year.

Full year adjusted net earnings included three favorable significant items totaling $30 million or $0.22 per share, which are detailed in our financial supplement. Overall, as compared to the prior year, adjusted net earnings reflect asset growth, growing fees from accretive flow reinsurance, steady owned distribution margin, and operating expense discipline driving scale benefit.

As Chris mentioned, our results have generated sustainable returns. Our fee income from accretive flow reinsurance has grown to $56 million for the full year 2025, up 37% over $41 million in 2024.

Our fee income from owned distribution margin contributed $47 million for the full year 2025, up 2% over $46 million in 2024. Our fee-based strategies, including flow reinsurance fee income and owned distribution margin, together with steadily growing IUL product fees, have contributed approximately 15% of F&G's adjusted net earnings, excluding significant items, for the full year 2025.

As we continue to execute on our strategy, we expect our share of fee-based earnings to grow to approximately 25% of our total earnings by year-end 2028. From a flow reinsurance perspective, we continue to expect to reinsure the vast majority of MYGA sales depending on economics.

As discussed on last quarter's call, with the reinsurance sidecar, we expect to evolve toward 50-50 retained versus flow for FIA sales. Importantly, we will continue to grow retained AUM as we balance retaining business versus optimizing flow reinsurance and preserving capital flexibility.

Our owned distribution portfolio is performing well and creating value. We have invested nearly $700 million in our four owned distribution investments and generated $80 million of EBITDA for the full year 2025.

Our holdings are diversified by product and market and reflect growing businesses with strong leadership. Two of our holdings are life IMOs that produced about 30% of F&G's IUL sales in full year 2025.

The other two holdings are annuity IMOs that produced approximately 10% of F&G's total annuity sales for the full year. In the future, we have opportunities to expand the value of owned distribution through our existing holdings.

As F&G grows, we are benefiting from increased scale, as our ratio of operating expense to AUM before flow reinsurance has decreased to 50 basis points at year-end 2025, down from 60 basis points at the end of 2024, meeting our target through a combination of growth in AUM and expense actions we've taken. As AUM grows and we continue to manage expenses, we expect the operating expense ratio to improve to approximately 45 basis points by year-end 2027, for a cumulative 15 basis points or 25% improvement over the three-year period.

F&G is uniquely positioned in the industry with a profitable and growing $57 billion in-force block that does not contain any problematic legacy business. Our asset and liability cash flows are well-matched.

Our retail fixed annuities are 92% surrender protected, and non-surrenderable liabilities include funding agreements, pension risk transfer, and immediate annuities. Over the past couple of years, both F&G and the industry have seen elevated terminations on annuities, which provide a boost to earnings from higher surrender charge fees when they occur.

Beyond that initial benefit, terminations contemporaneously pressure near-term spreads. As we move into 2026, this is a potential source of quarterly variability, and we feel that we benefit either way over the long term.

If terminations slow from the current pace, we forego the incremental surrender charge fee income, but benefit from retention of the underlying retained asset and profitable in-force liability. If terminations hold at the current level, we continue to benefit from higher surrender charge fee income and freed-up capital to deploy to new business with renewed surrender charges and longer surrender periods, resulting in stickier in-force liabilities that generate significant margins over time.

Next, I want to spend a few moments highlighting a capital transaction. We are on track to close a transaction during the first quarter with an investment firm, Ancient Financial Holdings LP, to sell F&G Life Re Limited, our Bermuda-based legal entity with affiliate-only reinsurance, effective March 1st.

In preparation for the sale, our Iowa operating company recaptured approximately $900 million or one-third of F&G Life Re's affiliated statutory liabilities at year-end. Approximately $600 million of this was ceded to an existing third-party reinsurance partner at year-end.

We expect to receive net proceeds of approximately $300 million from the sale of the legal entity and the remaining run-off in-force block, including a return of capital in the form of a $200 million dividend of assets at year-end 2025 from our Bermuda entity to our Iowa operating company. Blackstone will retain asset management for the in-force assets, and Ancient will manage assets under a new flow reinsurance treaty for MYGA new business.

After the transaction closes in the quarter, we expect AUM to decrease by $1.9 billion. The foregone annual adjusted net earnings are expected to be approximately $10 million per quarter before deployment of proceeds and future flow reinsurance fee income.

The transaction provides a number of benefits to F&G, including the transfer of capital through the dividend at year-end and the opportunity, through F&G's disciplined execution of risk transfer options, to dispose of a valuable asset that we no longer need to support our reinsurance strategy. The transaction also provides counterparty diversification for MYGA flow reinsurance from the future, as we are always looking to expand with high-quality flow partners.

As a reminder, F&G remains a U.S.-domiciled company. We are a full U.S.

taxpayer, and all new business is originated in our U.S. subsidiaries.

Turning now to our strong capital position. We remain committed to our long-term target of approximately 25% debt-to-capitalization, excluding AOCI, and we expect that our balance sheet will naturally delever over time.

We continue to target holding company cash and invested assets at two times interest coverage. Our annualized interest expense is approximately $165 million or roughly a 7% blended yield on the $2.3 billion of total debt outstanding.

We ended the year with an estimated company action level risk-based capital or RBC ratio of approximately 430% for our primary operating subsidiary, above our 400% target and boosted by the year-end recapture from the Bermuda legal entity. Importantly, F&G maintains strong capitalization and financial flexibility across all of our statutory balance sheets, including our offshore entities, which we conservatively manage to the most stringent capital requirements of our regulators and four rating agencies.

From a capital allocation perspective, during 2025, our capitalization supported sustained asset growth, and we returned $137 million of capital to shareholders through common and preferred dividends. Notably, we increased our quarterly common stock dividend by 14% in the fourth quarter as supported by our strong cash generation.

To wrap up, as I reflect on the past year, we have extended our proven track record and positioned F&G for long-term growth. To recap some highlights: we have executed on our strategy as we made continued progress toward our 2023 investor day targets and improved our operating expense ratio by 10 basis points; maintained a disciplined focus on our core products, including indexed annuities, indexed universal life, and pension risk transfer, allocating capital to the highest-return opportunities; significantly expanded in the earnings contribution of our fee-based flow reinsurance, middle-market life insurance, and owned distribution strategies alongside continued growth in our spread-based businesses; enhanced our strong capital position to fund our organic growth, now supplemented by the launch of our sidecar that provides long-term, on-demand capital; created flexibility to monetize the intrinsic value in our owned distribution strategy in the future; and we expanded our public float from 18% to 30%, enhancing market liquidity and broadening investor access to F&G shares.

As I look ahead to 2026, we remain focused on growing our core business and delivering long-term shareholder value by continuing to increase our assets under management, primarily through our core products, generating additional incremental scale benefit, expanding ROE excluding significant items, and moving further toward a more fee-based, higher margin, and less capital intensive business model, leveraging our position as one of the industry's largest sellers of annuities and life insurance. This concludes our prepared remarks, and now let me turn the call back to our operator for questions.

Good morning. Appreciate the opportunity, and hope you're all well.

My first question: can you talk about software exposure in the investment portfolio? If you're underexposed to that area, where is some overexposure where you believe there is a strength?

Thank you.

Hey John, it's Chris. Happy to start with that.

Software exposure for us is quite manageable. It's less than 5% of the total portfolio.

If you break that down further, obviously that's a huge category. We think it's less than 1% that has some potential for disruption or disintermediation risk.

Obviously, underwriting for AI risk is not a new topic for Blackstone. They've been on this theme for probably a decade now and really been focused on companies with durable use cases, high switching costs, structural moats, etc.

We feel really good about that exposure. Same thing on commercial real estate where we have I guess tenants that you would loosely call software tend to be the hyperscalers and these are long-term leases with cash flows and low LTVs, etc.

We think we're in really good shape there. I do think there's tremendous upside in the private equity portfolio, because, again, this is not a new theme.

Disruption cuts both ways, but I would say manageable on the credit side with some pockets of upside in the private equity portfolio.

Thank you for that. My next question: can you maybe talk about your near-term outlook for variable investment income given it kind of underperformed in the quarter?

John, at this point, I would say it's the same. We have a blended return on the current basis of approximately 10%, and as we mentioned in Chris's prepared remarks, we were in that sort of seven, seven and change, seven, seven and a half type range for the quarter, seven blended for the year.

It remains the same. We feel very confident in what's in our portfolio.

We did talk about we're going to do a geographic shift, if you will, in Q1, but I do not anticipate that there would be a commensurate change in the outlook and all that should net out to the same overall blended return. No real change.

I think there's probably an air of optimism relative to where we are, but we're trying to be a little careful on that. I think others had maybe similar perspectives with their fourth quarter returns and as they look into the beginning of 2026.

I think Conor hit it. The only thing I'd add, John, is that from a planning perspective, we plan for, I would say, continued mediocre returns, because I think that's the prudent thing for us to do.

There are some encouraging signs. We're starting to see more IPOs, more transaction activities.

Hopefully that continues, but our job's to not build a business plan around that.

I think, as obviously Blackstone are our partner for this. They have a good history of being a little on the conservative side, too, and having an increased value upon realization.

As this continues, we still feel very good about our portfolio.

Thanks for the answers. If I could ask one more, as I look in your supplement, you have a list of a number of your reinsurance partners, and I see Somerset Re in there, who has a relationship with the entity that's acquiring Brighthouse.

Can you talk about your diversified panel, your outlook for continued participation there by the existing partners, and general demand in the market? Thank you.

Sure, John. Thank you.

Let me, first of all, say, yes, I acknowledge obviously the relationship between Somerset and Aquarian. No indication of any kind from Somerset or Aquarian that anything would change with that relationship.

Let me be clear on that. We have a suite of partners here, in addition obviously to the sidecar with Blackstone.

We've got another one that we just told you about today with Ancient, pleased about that. There are others.

We have a lot of people who show up at our doorstep and who want to be our reinsurance partners. Honestly, individual appetites at these companies ebb and flow, you have to be prepared with a nice suite of partners.

No concerns at all. In fact, we probably have more partners than we can handle at the moment or could have more partners than we could handle.

Feeling very good about that and obviously happy to have another significant partner join us here on March 1st.

Thank you.

Hi. For the first one, I was hoping you could talk a little bit more about the transaction you mentioned and I think it sounded like you'd already gotten 200 into the statutory entity from that, and maybe another 100 coming.

I just wanted to check to make sure I had that right. Also just get your thoughts on sort of uses of that capital.

Thanks. Hey,

Alex, this is Chris. I'm just going to start with a little history of we set this up I want to say 6, 7 years ago, and at the time we thought we might have a path to be a flow reinsurer ourselves, and so there were some advantages to having a Bermuda operation.

Our strategy, as our organic business took off, our PRT business took off, we just didn't see that in our future, it had effectively become just a run-off block of assets. Yet we knew it was a pretty valuable entity, had a multi-year track record, audited financials, a team, etc.

Being approached by the folks at Ancient, who we thought were very credible potential partners, this looked like just a good opportunity to jettison an operation that really wasn't part of our go-forward strategic plans and pick up another partner. I'll let Conor talk about some of the details behind it.

Just the pieces, Alex, to your question. As we mentioned, we recaptured a third of it, reinsured or [unclear] reinsured 600 of that 900.

We've got 1.9 billion of AUM moving across. Proceeds of 300, of which 200 essentially has already been included in that RBC number at the end of the year.

Part of why the RBC number is in the 430 range. I think last year we were both sort of 410.

We don't obviously expect to continue to run the company at a 430 range, so that's some capital flexibility. Remaining therefore, just mathematically, proceeds of 300, 200 already, there's another 100 to come.

I would ascribe that towards general uses, sales, growing the business, very focused on growing AUM, but I would also take the chance to reiterate we're going to stay very disciplined. We will write great business when the opportunity arises.

If the margins are not there, we'll be a little patient, and if that means we have more cash and more capital along the way, then I think that's probably a good thing as well.

That's helpful. Thanks.

I wanted to also circle back on the surrender fees and how they're contributing to the crediting rate and just think through that a little. We've seen this at some other spread-based companies where there's been a drag of sorts that surprised people.

Where are the surrender fees, where do you expect them to go to? I just want to make sure I'm understanding and incorporating in my estimates enough ROA pressure, cuz we're forecasting your ROEs going up cuz you have this plan to send it up.

I just want to understand if that's going to take a little more time because of this dynamic or yeah, can you help us understand that?

Sure. There's quite a number of pieces to that.

If I maybe put it into an ROA context or the surrender fee income, we mentioned a little bit of this coming into the call. Obviously, it's been contributing to ROA.

Specifically to your question, we would expect that the volume of surrenders, and therefore the related surrender fee income, to be lower in '26 than '25. Now from an ROA perspective, there are other components as well.

We've highlighted the fact that we expect the investment ratio will continue to improve. I think all in all, I would imagine in the very near term, we might be kind of around where we are.

We may be in some element of a plateau. I think you're thinking about it the right way, right?

If surrenders come down, then we have more assets. Honestly, I think we would rather have the assets and if that meant a less muted expansion of ROA, but higher AUM, we would be good with that.

I think, yeah, I would argue I think that the prepayment number probably a little higher in '25 than we might see in '26, that's pretty modest. I wouldn't be surprised if we saw surrender-related fees down 20% roughly from where they are would be kind of where my head is thinking.

Obviously, a lot of that depends on external factors and interest rates and suitability rules at other companies and everything like that. It's hard to tell, but that frames the way we're thinking about it.

Alex, the only thing I would add to that, what Conor said, is just to link a couple things, because it's hard to isolate just one metric. There's no doubt ROA's been pumped up a little bit through excess surrender fees, but the same phenomenon that has caused that has also caused muted realizations in the PE portfolio, and that means that we've had to operate with significantly less capital.

Getting 7% versus 10 on $10 billion of AUM, that goes directly to capital. Seeing surrender fee income drop off a cliff would probably be driven by a pretty sharp move down in interest rates, which I think would have some offsetting positives for us.

Obviously it's all linked. Said another way, ROA would undoubtedly be lower if not for all the excess surrender fees, but my guess is AUM would be significantly higher than it is at this point, too.

That's helpful. I have a couple more, but I'll requeue.

Thanks.

Thank you. Good morning.

Conor, the 15 basis points of improvement over three years, could you refresh us on how that's going to break out? What are those specific big pieces that are going to contribute to that?

Really it's expense, obviously the ratio is AUM to expenses, but essentially what I would say in a nutshell is that we will keep our overall expenses, we actually aim to keep our expenses entirely flat year-over-year, '25 into '26. If you were going to peel into that a little bit between kind of the fixed and variable, I would say that while we continue to grow, we'll pull our fixed costs down a few percent in order to fund the variable, the offsetting few percent on the other side.

I want to make sure I'm answering your question, but that's really the overarching way is that we'll continue to grow, but we won't grow expenses. It's going to be another 10%, another 5 basis points, and we'll do everything we can to do that as quickly as we can.

Very good. Then what's latest thoughts in terms of the trajectory on RILA sales?

I think you're describing steady improvement, still off of a small base. How do you see that over the next couple of years?

We feel very good. Now we combine our RILA, so far we still combine our RILA with our FIA, but we talk about a lot of core products, but that might be the most core, if you will, the combination of FIA and RILA.

We're very pleased with RILA, but it's off a small base, right? We haven't been in the space that long, and as you know from everybody else, it takes a while to get going.

We're really, really happy with where RILA's going, and I would maybe just also echo really happy with where FIA and IUL are going. PRT obviously a bit seasonal, that's the other core one, you tend to do a lot more in the back half of the year than the front half, and then we'll remain opportunistic on FABN and MYGAs.

Appreciate that. Thank you.

Thanks, Mark.

Hey, good morning. You've had a little bit lower FABN quarter-over-quarter 4Q.

That was pretty similar to other issuers. Maybe just talk a little bit about any causes of the slowdown in the quarter and what is causing the bounce back in demand so far in 1Q '26?

Thanks.

Honestly, I think for us too, to repeat myself a little bit, it's opportunistic for us. We were very happy with what we wrote in terms of just deploying capital and find that really just the balance in total between volume and return.

In the third quarter, we had the opportunity to write an FABN where we had, I would say, an increased interest from the big, big asset managers, which helped pull in our credit spread. We were many many times oversubscribed.

I think it's been a good market, in fairness, for others as well. We came into the new year with a view of, well, let's see if that's still good or perhaps even better, and honestly it was.

It was a really good time. We came in right at the beginning of the year, January 6th.

It was a really good time to come into the market. It felt like a nice amount to put to work.

We could have written more than the 750, but you're trying to do the balancing act of getting the price where you want as well, you want to pull in your spreads, you want to be oversubscribed, and you want even more of the big asset managers, and at this stage we have essentially them all. Really very pleased with that, and now we sit back.

I think you're probably aware at this stage now where we have to wait till after all the statutory filings and stuff are done, we won't even have an opportunity until late in the second quarter. FABNs are not something we'll do every quarter.

We'll come in in an eye just as we see the prevailing tradewinds being very effective. I would have a reasonable expectation we'll do more during the year, but as to exactly which quarter it'll fall into, we'll be very much market dependent.

Thank you. Then maybe you could talk a little bit about MYGA sales.

Seems like there's been a bit of a pivot towards the index products. Is that something you expect to continue to see given the interest rate environment changing a little bit?

Maybe just give us a little color there. Thanks.

I'll be careful here because each company has maybe a slightly different view here, and I'll speak specifically about ours. We are seeing better relative returns elsewhere, meaning across the core products.

Look, we're still in the MYGA business, we will continue to write MYGA, but we'll be a little more selective about it. We are entirely prepared to write less here and deploy that capital in other places.

That's right now, there are times even last year there was quite I think a significant fluctuation between Q1 and Q2. We had a quiet first quarter, a big second quarter, and I think the rest of the year we're kind of in between those bookends.

Yes, to be even more specific, we continue to view the opportunities as being better in other products, even as we head into early 2026 here as well.

Wilma, it's Chris. The only thing I would add to what Conor said is I wouldn't call it a pivot.

I think for seven years now our number one priority is always been grow FIAs, right? Then we added RILA, PRT, and if the returns are there, MYGA.

We reinsure the vast majority of our MYGA out. If the returns and the demand from the reinsurers are there, we will certainly write it.

If there are more attractive places to put capital, we will do that. It just happened to be that I think FABN in particular was more attractive from a return perspective than writing extra MYGA at the margin.

Hopefully that helps.

That's right. We have been seeing certainly over the last few years a top 10 writer in all of these in FIA, in IUL, in PRT, and in MYGA.

We'll move up and down that leaderboard a little bit as the opportunity shift.

Thank you.

Thanks, Wilma.

Hey, thanks for taking the follow-up. I wanted to ask you a bit about just sort of high-level view on valuation.

I heard you on de-risking some of the fixed income. I thought that was interesting.

I think one of the things that maybe holds people back from giving you credit for the fee-based business you have is just the sheer magnitude of the net investment income that comes from your alternative investments and the other parts of the non-fixed income portfolio. Is there anything you can do there to sort of ease some of the tension there with shareholders or the way investors are viewing it?

Is that something that you guys contemplate?

This is Chris. I'll start and just say, from a valuation standpoint, we're trading at $0.62 of book value.

You tell me. Historically that is associated with companies with massively toxic liabilities, not a pristine, fixed book of surrender-charge-protected FIAs and non-surrenderable liabilities.

It's extreme, the valuation difference right now. We've tried to give a lot more disclosure this quarter around credit and specifically what's in the private credit portfolio, hopefully that helps, including refreshed stress test numbers.

The stock is trading as though there are billions and billions of credit losses coming. It's pretty inexplicable to me, to be quite honest.

I would say we have two other assets that are quite undervalued: one is our cultural-market life insurance business, which is a quite valuable asset, and then the other is owned distribution, which we spent quite a bit of time on, which I think we have multiple avenues to monetize that business over time. I think it is extreme.

I will defer to Conor on alternatives. It's one of the reasons we have split out the equity component, because we were sort of capturing and defining alternatives as anything that showed up on a certain schedule.

It's not the right way to think about it. The majority of that portfolio is investment grade and in the vast majority of cases investment-grade fixed income.

Conor, I'll defer to you if there's more you want to add to that VII discussion.

Yeah. I'll say a couple of things.

Broadly speaking across the portfolio, I mean it's been pretty pristine. I've I've heard others, be very proud of their low double-digit, impairment-related numbers over the last few years, and, we're half of that.

So, I get why people are concerned, but in terms of what's in our portfolio and how well it's been performing, it it it has been, it has been very noteworthy for us. We did There's definitely an attempt, I mean I I feel, that there's a kind of a lowest common denominator, where where we're viewed perhaps as a single business that's heavily spread rather than kind of component parts like life or own distribution, etc., as Chris alluded to.

That was why this was a a There was a significant attempt to help rectify that with this new disclosure around fee versus spread, because, we wanted to demonstrate that we have actively made a ver- very significant shift here. We've talked about an expansion from, I think, in the in the disclosures, we talked about going from less than 5% to to 15.

I I would actually argue it's probably closer to like zero to 15, because if you did a full attribution of expenses and debt to that what was essentially the life business like 3 years ago, it would have been, it would have been very small. Now that 15% of our earnings are coming from the fee, business, and, and you can see that we have an expectation that that will grow to 25 just organically, without, without anything else over the next 3 years, over the 3 years of the plan cycle.

That's definitely a step in that direction. We're going to continue to talk about it, we'll increase our, exposures and and and perhaps even related educations around th- those businesses, the owned distribution business, the life business, as we go here.

Hopefully that will help. Obviously we need, the old portfolio, the I think the disclosure changes we'll make next quarter will help as well, but at the end of the day, obviously we as Chris said, we have an expectation, near-term expectation, that we're not quite at that we're not going to get to that 10% quite yet.

But, but obviously that will help a lot. I guess Chris pristine absolutely pristine set of liabilities.

There's nothing, it's it's a young, clean book of business, there's really nothing to be concerned of there, very well surrender protected, performing very much in line with our expectations, we'll see.

Maybe a follow-up to that is, when I think about the last couple years, even the non-fixed income just being closer to 7% to hit this funding requirements for your growth, I think in both the last two years, there were things that happened, right? There was an equity raise one of the years, and then this year, there's the selling of legal entity, which is, it's good you have that tool this year, for sure.

Did the private equity returns have to be 10% plus for you guys to be self-funding? Is that an incorrect takeaway from that?

How would you describe that? No.

All right, I'm going to start with thank you. I'm actually really glad you asked the question that way.

No. You're right.

I have a sense that the equity raise perhaps raised concerns that we either needed to continue to rely on FNF or the equity markets to have the capital to write business, and that's not the case. We've done everything we can to allay those fears in the quarter since then, and I will reiterate today that we are capital independent.

We have the capital we need to continue to grow AUM, continue to write business, etc., etc. At this stage, the book is essentially throwing off all of the capital that we would need to write all the business that we would want to write.

That is not the case. I would also suggest, too, that yes, on average over the long term, we expect these returns.

If they are delayed in coming, we have been measured in our expectation even in our plan cycle as well. In a scenario if the scenario is that it remains at more of a 7-ish range, we're absolutely fine.

We might write at the lower end of our sales target volumes, but again, I think our sales volumes are going to be tied more to market opportunity and the best uses of capital. I do not feel that capital is a constraint, sitting here with my call it my CFO hat on.

I think the constraint a little bit is just what will the earnings opportunity be in the marketplace, and therefore we'll decide how much we want to write and where we want to put them. Absolutely from a capital point of view, we are capital self-sufficient, capital independent.

We're all good.

All right, thanks for all the responses. Appreciate it.

Bye.

Thanks, Alex.

Great. Thanks again, everyone, for joining the call this morning.

We delivered a strong finish to an outstanding year and continue to execute on our strategy toward a more fee-based, higher margin, and less capital intensive business model. Looking ahead to 2026, we remain focused on continuing to grow our core business and delivering long-term shareholder value.

We appreciate your interest in F&G and look forward to updating you on our first quarter earnings call.